Status:
COMPLETED
Hepatitis D Virus Infection Among Hepatitis B Virus Surface Antigen Positive Individuals
Lead Sponsor:
Assiut University
Conditions:
HDV Infection
HBV Infection
Eligibility:
All Genders
18-60 years
Brief Summary
Globally, about 248 million people are chronic HBV surface antigen carriers, and about 5% of them also had hepatitis delta virus (HDV) infection as well. The prevalence of HBsAg in Egypt is intermedia...
Eligibility Criteria
Inclusion
- HBV related liver disorder, aged 18-60 years.
- HBsAg positive individuals were divided into different clinical categories according to EASL 2012 and we revised this classification according to EASL 2017. HBeAg negative chronic infection; HBeAg positive chronic infection), Acute hepatitis, Fulminant hepatitis, Chronic hepatitis (HBeAg positive and HBeAg negative), Liver cirrhosis, and Primary HCC.
Exclusion
- Dual infection with other viruses as HCV and/or HIV, auto-immune or alcoholic hepatitis.
Key Trial Info
Start Date :
November 1 2015
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2017
Estimated Enrollment :
186 Patients enrolled
Trial Details
Trial ID
NCT04038372
Start Date
November 1 2015
End Date
October 1 2017
Last Update
July 30 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.